Myelodysplastic/myeloproliferative Disease - 25 Studies Found
Completed |
: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer :
|
Completed |
: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes :
|
Completed |
: 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome :
|
Completed |
: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome :
|
Completed |
: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia :
|
Completed |
: Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) :
|
Active, not recruiting |
: Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia :
|
Completed |
: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS :
|
Completed |
: Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer :
|
Completed |
: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome :
|